Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies. (Q38133770)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2013

Language	Label	Description	Also known as
English	Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.	scientific article published on September 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Luís Fernando Tófoli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Mario F. Juruena

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Mario F. Juruena

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jair de Jesus Mari

1

object named as

Jair de Jesus Mari

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Alessandra Diehl

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Angélica M Claudino

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

73

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1549-1568

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Grand challenges in global mental health

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Global burden of disease in young people aged 10-24 years: a systematic analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

No health without mental health

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

What is the best approach to treating schizophrenia in developing countries?

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Packages of care for mental, neurological, and substance use disorders in low- and middle-income countries: PLoS Medicine Series

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

A United Nations General Assembly Special Session for mental, neurological, and substance use disorders: the time has come

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Treating depression in primary care in low-income women in Santiago, Chile: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Health workforce skill mix and task shifting in low income countries: a review of recent evidence

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

PRIME: a programme to reduce the treatment gap for mental disorders in five low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Lay health worker led intervention for depressive and anxiety disorders in India: impact on clinical and disability outcomes over 12 months

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Generalized anxiety disorder: prevalence, burden, and cost to society

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Multiple pathways to functional impairment in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The public health aspects of complex emergencies and refugee situations

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

A systematic review of factors influencing the psychological health of conflict-affected populations in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Somatization and mental health: a comparative study of the idiom of distress hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Influence of cultural and social factors on the epidemiology of idiopathic somatic complaints and syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Latent class analysis of co-morbidity in the Adult Psychiatric Morbidity Survey in England 2007: implications for DSM-5 and ICD-11.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Comparing the symptoms of posttraumatic stress disorder with the distress and fear disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The mental health workforce gap in low- and middle-income countries: a needs-based approach

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Pharmacotherapy for social anxiety disorder: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The pharmacologic treatment of anxiety disorders: a review of progress

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Benzodiazepines revisited—will we ever learn?

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The evidence-based pharmacological treatment of social anxiety disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Treatment of specific phobia in adults

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Medicinal plants for the treatment of generalized anxiety disorder: a review of controlled clinical studies

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Efficacy of treatment for somatoform disorders: a review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Recent developments in the understanding and management of functional somatic symptoms in primary care

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, or pain

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Towards better understanding and management of somatoform disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Management of psychiatric comorbidity in fibromyalgia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Antidepressants for neuropathic pain: a Cochrane review.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Chronic fatigue syndrome: aetiology, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Outcome of anxiety and depressive disorders in primary care

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Detection of psychiatric morbidity in the primary medical care setting in Brazil.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Review of the guidelines of the Brazilian Medical Association for the treatment of depression (Complete version)

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The co-occurrence of bipolar and substance use disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Packages of care for schizophrenia in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Mortality in schizophrenia: a measurable clinical endpoint

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

A systematic review of the prevalence of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Primary health care: making Alma-Ata a reality

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Family-based intervention for schizophrenic patients in China. A randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Cost-effectiveness evaluation of compliance therapy for people with psychosis.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Resources for mental health: scarcity, inequity, and inefficiency

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Early intervention in psychosis: a map of clinical and research initiatives in Latin America.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Chlorpromazine and the Psychopharmacologic Revolution

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Patterns of Usual Care for Schizophrenia: Initial Results From the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Evidence-based pharmacotherapy of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Epidemiology of eating disorders: incidence, prevalence and mortality rates

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The epidemiology of eating disorder behaviors: an Australian community-based survey

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Prevalence and correlates of binge eating disorder in a community sample

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Eating disorders in white and black women

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Eating disorder behaviors are increasing: findings from two sequential community surveys in South Australia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Are eating disorders a significant clinical issue in urban India? A survey among psychiatrists in Bangalore

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The economic cost of brain disorders in Europe

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Empirical classification of eating disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Risk factors for eating disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Eating disorders: an Indian perspective

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Rationales for Food Refusal in Chinese Patients with Anorexia Nervosa

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Tendency toward deliberate food restriction, fear of fatness and somatic attribution in cross-cultural samples

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Eating disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Review and meta-analysis of pharmacotherapy for binge-eating disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Antidepressants in short-term treatment of binge eating disorder: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Clinical psychopharmacology of eating disorders: a research update

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Placebo-controlled trial of sertraline in the treatment of binge eating disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Epidemiology of fetal alcohol syndrome in a South African community in the Western Cape Province

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

New horizons for therapeutics in drug and alcohol abuse

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Novel pharmacotherapeutic treatments for cocaine addiction

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Pharmacotherapies for alcohol abuse. Withdrawal and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Pharmacotherapy for smoking cessation: current advances and research topics

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Adverse effects and tolerability of medications for the treatment of tobacco use and dependence

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The epidemiology of epilepsy revisited

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Epilepsy stigma perception in an urban area of a limited-resource country

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The global burden and stigma of epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The pharmacological treatment of epilepsy in adults

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Rethinking mental illness

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Advancement of global health: key messages from the Disease Control Priorities Project

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The rise of eating disorders in Japan: issues of culture and limitations of the model of "westernization".

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Television, disordered eating, and young women in Fiji: negotiating body image and identity during rapid social change

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Eating attitudes and body dissatisfaction in adolescents: Cross-cultural study

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Case studies of tobacco dependence treatment in Brazil, England, India, South Africa and Uruguay.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Packages of care for alcohol use disorders in low- and middle-income countries.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

The business of addiction treatment: A research agenda.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Knowledge of and stigma associated with mental disorders in a South african community sample

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Global disparities in the epilepsy treatment gap: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0113-4

21 January 2018

Prevalence and sociodemographic correlates of eating disorder endorsements among adolescents and young adults from China

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment gap in mental health care

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy of anxiety disorders: a critical review

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brief motivational interview and educational brochure in emergency room settings for adolescents and young adults with alcohol-related problems: a randomized single-blind clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The world health report 2002 - reducing risks, promoting healthy life

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melancholia in Latin American studies: a distinct mood disorder for the ICD-11.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obsessive compulsive disorder: diagnosis and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chlorpromazine versus placebo for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to antiretroviral therapy & its determinants amongst HIV patients in India

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The global burden of epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haloperidol versus placebo for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-Effectiveness of a Primary Care Treatment Program for Depression in Low-Income Women in Santiago, Chile

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus placebo for out-patients with anorexia nervosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early psychological interventions to treat acute traumatic stress symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome results of two levels of intervention in low-income women with depressive symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of bulimia with bupropion: a multicenter controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chlorpromazine and the psychopharmacologic revolution

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depot fluphenazine decanoate and enanthate for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Valerian for anxiety disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guidelines of the Brazilian Medical Association for the treatment of depression (complete version)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttraumatic stress disorder: the burden to the individual and to society

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice guideline for the treatment of patients with obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychological treatments for bulimia nervosa and binging

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressants versus placebo for people with bulimia nervosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evidence-based strategy for remission in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptoms and Syndromes of Bodily Distress: An Exploratory Study of 978 Internal Medical, Neurological, and Primary Care Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating chronic fatigue syndrome - a study into the scientific evidence for pharmacological treatments.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kava extract versus placebo for treating anxiety

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Diagnostic reliability in mental disorders of the International Classification of Diseases in primary care]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eating disorder risk behavior in Brazilian adolescents from low socio-economic level

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate and early behavioral interventions for the prevention of acute and posttraumatic stress disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatization in Latin America: a review of the classification of somatoform disorders, functional syndromes and medically unexplained symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Passiflora for anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressants and cognitive-behavioral therapy for symptom syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of fibromyalgia and comorbid psychiatric disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24000001

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40265-013-0113-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24000001%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38133770&oldid=2201315314"